Metformin Inhibits the NLRP3 Inflammasome via AMPK/mTOR-dependent Effects in Diabetic Cardiomyopathy

Metformin is a widely used antidiabetic drug for type 2 diabetes that can play a cardioprotective role through multiple pathways. It is a recognized agonist of AMP-activated protein kinase (AMPK) that blocks mitochondrial complex I. The NLRP3 inflammasome has been demonstrated to be activated in dia...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Biol Sci
Main Authors: Yang, Fan, Qin, Ying, Wang, Yueqiu, Meng, Songyan, Xian, Huimin, Che, Hui, Lv, Jie, Li, Yang, Yu, Yahan, Bai, Yunlong, Wang, Lihong
Formato: Artigo
Idioma:Inglês
Publicado em: Ivyspring International Publisher 2019
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6535781/
https://ncbi.nlm.nih.gov/pubmed/31182921
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/ijbs.29680
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados